Is the patient on immunotherapy?

Warning

Is the patient on immunotherapy? (such as pembrolizumab, nivolumab, ipilimumab, atezolizumab, avelumab, durvalumab, cemiplimab)?

Immune-related gastrointestinal toxicity1.

Symptoms: diarrhoea, abdominal pain, PR bleeding, fever, vomiting.

1. Abridged from: NHS Lothian Immunotherapy toxicity management guidelines v7.0. S Clive & C Barrie. Last reviewed: 22.11.2021.

Editorial Information

Last reviewed: 22/11/2021

Next review date: 22/11/2024

Author(s): Clive S, Barrie C.

Version: 7.0

Reviewer name(s): Stewart J.